Zhu, Vivienne J.Tu, WanzhuMarrero, David G.Rosenman, Marc B.Overhage, J. Marc2013-09-042013-09-042011-10Zhu, V. J., Tu, W., Marrero, D. G., Rosenman, M. B., & Overhage, J. M. (2011). Race and medication adherence and glycemic control: findings from an operational health information exchange. In AMIA Annual Symposium Proceedings (Vol. 2011, p. 1649). American Medical Informatics Association.https://hdl.handle.net/1805/3517The Central Indiana Beacon Community leads efforts for improving adherence to oral hypoglycemic agents (OHA) to achieve improvements in glycemic control for patients with type 2 diabetes. In this study, we explored how OHA adherence affected hemoglobin A1C (HbA1c) level in different racial groups. OHA adherence was measured by 6-month proportion of days covered (PDC). Of 3,976 eligible subjects, 12,874 pairs of 6-month PDC and HbA1c levels were formed between 2002 and 2008. The average HbA1c levels were 7.4% for African-Americans and 6.5% for Whites. The average 6-month PDCs were 40% for African-Americans and 50% for Whites. In mixed effect generalized linear regression analyses, OHA adherence was inversely correlated with HbA1c level for both African-Americans (−0.80, p<0.0001) and Whites (−0.53, p<0.0001). The coefficient was −0.26 (p<0.0001) for the interaction of 6-month PDC and African-Americans. Significant risk factors for OHA non-adherence were race, young age, non-commercial insurance, newly-treated status, and polypharmacy.en-USType 2 diabetesCentral Indiana Beacon Communitymedication adherenceglycemic controlArticle